RNASET2 and ovarian carcinoma: In several instances, RNASET2 levels were found to be decreased in advanced tumors, such as ovarian cancer, gastric cancer, and acute lymphocytic leukemia, as expected for a classical tumor suppressor gene and/or an alarmin-like molecule [95,122].